| PALM HARBOR, Florida – -(October 22, 2012)- – Eight local HCA Hospitals participated in the national Randomized Evaluation of Decolonization versus Universal Clearance to as Eliminate (REDUCE) MRSA Trial study with results released today showing that universal treatment of all patients in the Intensive Care Unit (ICU) setting dramatically reduced methicillin-resistant staphylococcus aureus (MRSA) by 37 percent and the risk of all bloodstream pathogens by 44 percent.
Local participating HCA hospitals included: Blake Medical Center, Brandon Regional Hospital, Doctors Hospital of Sarasota, Fawcett Memorial Hospital, Largo Medical Center, Medical Center of Trinity (the former Community Hospital), Regional Medical Center Bayonet Point and South Bay Hospital.
“Providing excellent care for our patients is our top priority and we are always eager to implement demonstrated practices that can keep our patients healthier during their hospital stays,” said Linda Lemon-Steiner, FACHE, CHCQM-CM, MPH, RN, Vice President for Quality and Clinical Operations, HCA West Florida. “It is an expansion of our Aim for Zero and MRSA initiatives to aggressively prevent infections in our hospitals through the consistent application of evidence-based interventions, the effective and efficient use of antibiotics and education.”
The three-arm, randomized study included 74 adult ICUs, located in 43 hospitals in 16 states. The one-year baseline period from January – December 2009 included 43,390 patient admissions followed by an 18-month intervention period, April 2010 – September 2011, involving 74,256 patient admissions.
REDUCE MRSA Trial – 2
All ICUs in study hospitals were assigned the same strategy, which was one of the following:
The study results released for the first time at IDWeek 2012™ show strong evidence that the widely used practice of Screening and isolation for MRSA are not as effective as Universal decolonization, or treating all patients in the ICU setting with the an ointment and antimicrobial soap.
The REDUCE MRSA study was conducted in conjunction with investigators at Harvard and several other academic institutions, and research programs at two U.S. Department of Health and Human Services agencies, the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).
IDWeek™ is an annual meeting of infectious disease organizations that convenes leading researchers to showcase the latest developments in the field.
October 14-20, 2012, is International Infection Prevention Week. This initiative provides an opportunity for healthcare professionals, consumers, organizations and family members to shine the light on infection prevention and its ability to save lives. For more information, visit www.apic.org/IIPW.
About HCA West Florida
HCA West Florida is a comprehensive network of hospitals, outpatient surgery and diagnostic imaging facilities, physician practices, medical education and training programs and a complete continuum of specialized health programs and services that meet the healthcare needs of residents and businesses in West and Central Florida communities. Affiliated facilities include 15 hospitals on 17 campuses, 16 ambulatory surgery centers, numerous diagnostic imaging and occupational health sites, an integrated regional lab and consolidated service center. Twelve of the 15 hospitals were recently named Top Performers on Key Quality Measures™ by The Joint Commission, the leading accreditor of healthcare organizations in America. All 15 hospitals are Primary Stroke Centers and 14 are Accredited Chest Pain Centers. With an economic impact of $1.68 billion, HCA West Florida hospitals cared for more than 1.19 million patients in 2011. In Florida, HCA is a comprehensive network of 38 hospitals operating 9,800 licensed beds, and one of the state’s largest employers. The parent company, HCA, is the nation’s leading provider of healthcare services.